Ramiah Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Ramiah Investment Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Sell	3,867 -141	-4%	-$8.1K	0.17%	71
2026 Q1	$243K	Sell	4,008 -202	-5%	-$11.8K	1.62%	30
2025 Q4	$227K	Buy	+4,210	New	+$203K	0.2%	61
2020 Q1	–	Sell	-4,755	Closed	-$305K	–	75
2019 Q4	$305K	Buy	+4,755	New	+$272K	0.3%	53

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Ramiah Investment Group's BMY Position: Q2 2026 in Review

Ramiah Investment Group reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, selling an estimated $8.1K and leaving 3,867 shares worth $223K. The position accounts for 0.17% of the portfolio, ranked #71.

Ramiah Investment Group first reported a position in BMY in Q4 2019 and has held it in 4 quarters since. The position peaked at $305K in Q4 2019. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Ramiah Investment Group held 3,867 shares of Bristol-Myers Squibb worth $223K as of Q2 2026.
Ramiah Investment Group sold 141 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.1K.
Bristol-Myers Squibb made up 0.17% of Ramiah Investment Group's portfolio in Q2 2026, its #71 holding.
Ramiah Investment Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 4 quarters since.
Ramiah Investment Group's Bristol-Myers Squibb position peaked at $305K in Q4 2019.
832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.